Video

Alan Thompson from Royal College London: Rapid Progress Made in Progressive Multiple Sclerosis

Author(s):

Patients diagnosed with relapsing remitting multiple sclerosis have seen their treatment options increase dramatically in recent years. Now patients with the progressive forms are seeing the the start of momentum building in their favor.

Patients diagnosed with relapsing remitting multiple sclerosis have seen their treatment options increase dramatically in recent years. Now patients with the progressive forms are seeing the the start of momentum building in their favor.

Alan Thompson, MD, from University College London, and one of the leaders of the Progressive MS Alliance discussed the latest developments in treatment, including a trio of awards presented by the alliance at the annual ECTRIMS meeting in London. The awards, given to some of the leading minds in the field on international projects are meant to help keep the momentum moving forward and show demonstrable over the next four years and beyond.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.